Association of hematological toxicity (tox) and outcome to doxorubicin (DOX) in advanced soft tissue sarcoma (STS): A retrospective analysis of the EORTC-Soft Tissue and Bone Sarcoma Group database

Authors :: Ian Judson
Stefan Sleijfer
Ron H.J. Mathijssen
Saskia Litière
Alessandro Gronchi
Hans Gelderblom
Winette T. A. van der Graaf
Elisa Rizzo
Antoine Italiano
Source :: Journal of Clinical Oncology. 33:10544-10544
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: 10544 Background: DOX pharmacokinetics vary substantially between patients leading to large differences in systemic drug levels. Given potential dose-effect relations, patients with the greatest to...

Subjects :: Oncology
Cancer Research
Pathology
medicine.medical_specialty
business.industry
Soft tissue sarcoma
Soft tissue
Bone Sarcoma
medicine.disease
Drug levels
Pharmacokinetics
Hematological toxicity
Internal medicine
Retrospective analysis
Medicine
Doxorubicin
business
medicine.drug

Tools